1. Volume 57, Issue 1, Pages 224-231 (January 2000)
Renal hemodynamics and pharmacokinetics of bosentan with and without cyclosporine A 
Isabelle Binet, M.D., Andreas Wallnöfer, Cornelia Weber, Richard Jones, Gilbert Thiel 
Kidney International 
Volume 57, Issue 1, Pages (January 2000)
DOI: /j x
Copyright © 2000 International Society of Nephrology Terms and Conditions

2. Figure 1
Study design.
Kidney International  , DOI: ( /j x)
Copyright © 2000 International Society of Nephrology Terms and Conditions

3. Figure 2
Systolic/diastolic blood pressure. Mean results (± SEM) of hourly blood pressure measurements during clearance assessment after placebo (•; baseline), seven days of CsA + placebo (▴), and seven days of CsA + BO regular intake (▪).
Kidney International  , DOI: ( /j x)
Copyright © 2000 International Society of Nephrology Terms and Conditions

4. Figure 3
Glomerular filtration rate. Mean results (± SEM) of hourly inulin clearance after placebo (•; baseline), seven days of CsA + placebo (▴), and seven days of CsA + BO regular intake (▪).
Kidney International  , DOI: ( /j x)
Copyright © 2000 International Society of Nephrology Terms and Conditions

5. Figure 4
Renal plasma flow. Mean results (± SEM) of hourly PAH clearance after placebo (•; baseline), seven days of CsA + placebo (▴), and seven days of CsA + BO regular intake (▪).
Kidney International  , DOI: ( /j x)
Copyright © 2000 International Society of Nephrology Terms and Conditions